| Primary reference | Discovery of 3(S)-thiomethyl pyrrolidine ERK inhibitors for oncology., Boga SB, Alhassan AB, Cooper AB, Doll R, Shih NY, Shipps G, Deng Y, Zhu H, Nan Y, Sun R, Zhu L, Desai J, Patel M, Muppalla K, Gao X, Wang J, Yao X, Kelly J, Gudipati S, Paliwal S, Tsui HC, Wang T, Sherborne B, Xiao L, Hruza A, Buevich A, Zhang LK, Hesk D, Samatar AA, Carr D, Long B, Black S, Dayananth P, Windsor W, Kirschmeier P, Bishop R, Bioorg Med Chem Lett. 2018 Jun 15;28(11):2029-2034. doi:, 10.1016/j.bmcl.2018.04.063. Epub 2018 Apr 26. PMID:29748051 |